TOP TIERMARKET NEWSWIRE

News & sentiment

ALVOTECH (ALVO) — News & AI sentiment

ALVOTECH (ALVO) news roundup. 23 stories aggregated over the last 30 days. Average 30-day sentiment is 57.6/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

23

avg sentiment 57.6/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

ALVO news in the last 24 hours, 7 days, 30 days and 90 days

How much ALVO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	ALVO stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	23	57.6/100	ALVO headlines →
Last 90 days	45	52.1/100	ALVO headlines →

Latest stories on ALVO

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

Business Insider67 · bullishproduct/pr

Aug 31

Alvotech to present at upcoming investor conferences in September

GlobeNewswire56 · neutralgeneral

Aug 27

Alvotech to present at upcoming investor conferences in September

Business Insider56 · neutralgeneral

Aug 27

Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow?

Yahoo Top63 · neutralanalyst

Aug 24

Alvotech advances 18%, accelerating post-earnings rally

Seeking Alpha73 · bullishearnings

Aug 24

Alvotech Expands U.S. Reach with $150 Million Deal: Strategic Partnership with Lotus Sets New Stage for Biosimilars August 24, 2026

MarketChameleon73 · bullishm&a

Aug 24

BofA initiates Alvotech stock with buy rating on biosimilar platform

Investing.com Analyst Ratings61 · neutralanalyst

Aug 24

Alvotech initiated with a Buy at BofA

The Fly61 · neutralanalyst

Aug 24

Alvotech 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Aug 21

Alvotech Strikes $150 Million Biosimilar Deal With Lotus for U.S. and Key Asian Markets

TipRanks67 · bullishm&a

Aug 21

Alvotech enters licensing, commercialization agreement with Lotus Pharmaceutical

The Fly63 · neutralgeneral

Aug 21

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

Business Insider63 · neutralproduct/pr

Aug 21

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

GlobeNewswire63 · neutralproduct/pr

Aug 21

Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts

Seeking Alpha47 · neutralanalyst

Aug 20

Alvotech Bolsters Pipeline and Financial Position Despite Revenue Dip—2026 Outlook Remains Strong August 20, 2026

MarketChameleon63 · neutralgeneral

Aug 20

Alvotech (ALVO) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 20

Alvotech Q2 Earnings Call Highlights

Yahoo Finance56 · neutralearnings

Aug 20

Alvotech Files H1 2026 Results and Schedules Business Update Call

TipRanks50 · neutralgeneral

Aug 19

Alvotech reports 1H results

Seeking Alpha42 · neutralearnings

Aug 19

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

GlobeNewswire50 · neutralearnings

Aug 19

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Business Insider50 · neutralearnings

Aug 19

Alvotech Q2 2026 Earnings Preview

Seeking Alpha38 · neutralearnings

Aug 18

Alvotech initiated with an Outperform at Evercore ISI

The Fly63 · neutralanalyst

Aug 16

Evercore ISI initiates Alvotech stock with outperform rating

Investing.com Analyst Ratings61 · neutralanalyst

Aug 14

Alvotech to Report Financial Results for H1 2026

Business Insider50 · neutralgeneral

Aug 10

Open ALVO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →